安法斯塔製藥公司
US ˙ NasdaqGS ˙ US03209R1032

簡介

本頁面提供了有關 Howard Lee 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Howard Lee已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:AMPH / Amphastar Pharmaceuticals, Inc. Director 159,350
如何解讀這些圖表

以下圖表顯示了在Howard Lee進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AMPH / Amphastar Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AMPH / Amphastar Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2014-08-25 AMPH Lee Howard 6,000 10.8370 6,000 10.8370 65,022 304 18.1900 44,118 67.85

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
AMPH / Amphastar Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AMPH / Amphastar Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2023-06-01 AMPH Lee Howard 16,679 45.0243 16,679 45.0243 750,960 322 38.6500 -106,317 -14.16
2022-06-06 AMPH Lee Howard 10,291 37.7863 10,291 37.7863 388,859
2022-05-23 AMPH Lee Howard 10,000 34.9323 10,000 34.9323 349,323
2021-06-08 AMPH Lee Howard 8,000 19.3135 8,000 19.3135 154,508
2021-06-07 AMPH Lee Howard 7,827 19.2847 7,827 19.2847 150,941
2021-05-20 AMPH Lee Howard 10,000 19.7354 10,000 19.7354 197,354
2020-05-26 AMPH Lee Howard 10,000 18.5989 10,000 18.5989 185,989
2020-05-22 AMPH Lee Howard 10,000 18.3639 10,000 18.3639 183,639
2020-05-21 AMPH Lee Howard 10,000 18.4687 10,000 18.4687 184,687
2020-05-20 AMPH Lee Howard 17,782 18.4332 17,782 18.4332 327,779
2018-12-07 AMPH Lee Howard 9,278 21.8866 9,278 21.8866 203,064
2018-12-06 AMPH Lee Howard 4,206 20.9100 4,206 20.9100 87,947
2018-12-06 AMPH Lee Howard 5,794 21.4522 5,794 21.4522 124,294
2018-12-04 AMPH Lee Howard 8,989 21.8450 8,989 21.8450 196,365
2018-12-04 AMPH Lee Howard 1,011 22.5455 1,011 22.5455 22,794
2016-11-15 AMPH Lee Howard 17,994 20.7575 17,994 20.7575 373,510
2016-11-14 AMPH Lee Howard 20,000 20.5585 20,000 20.5585 411,170
2016-09-01 AMPH Lee Howard 10,381 18.7763 10,381 18.7763 194,917
2015-12-16 AMPH Lee Howard 1,926 14.3300 1,926 14.3300 27,600
2015-12-15 AMPH Lee Howard 36,536 14.3420 36,536 14.3420 523,999

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Howard Lee 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-06-03 2026-06-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -769 159,350 -0.48 18.45 -14,188 2,940,008
2026-06-03 2026-06-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 8,143 160,119 5.36
2025-06-04 2025-06-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -923 151,976 -0.60 26.01 -24,007 3,952,896
2025-06-04 2025-06-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 5,122 152,899 3.47
2024-06-05 2024-06-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -579 147,777 -0.39 42.04 -24,341 6,212,545
2024-06-05 2024-06-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 3,076 148,356 2.12
2023-06-12 2023-06-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -375 145,280 -0.26 45.67 -17,126 6,634,938
2023-06-07 2023-06-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 2,716 145,655 1.90
2023-06-05 2023-06-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -16,679 142,939 -10.45 45.02 -750,960 6,435,728
2023-06-05 2023-06-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 16,679 159,618 11.67 16.69 278,373 2,664,024
2022-06-14 2022-06-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 4,163 142,939 3.00
2022-06-07 2022-06-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,291 138,776 -6.90 37.79 -388,859 5,243,832
2022-06-07 2022-06-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,291 149,067 7.42 17.11 176,079 2,550,536
2022-05-25 2022-05-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 10,291 -49.28
2022-05-25 2022-05-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,000 138,776 -6.72 34.93 -349,323 4,847,765
2022-05-25 2022-05-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 148,776 7.21 17.11 171,100 2,545,557
2021-06-14 2021-06-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -157 138,776 -0.11 19.92 -3,127 2,764,418
2021-06-08 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
D - Sale to Issuer -8,000 0 -100.00
2021-06-08 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -8,000 138,933 -5.44 19.31 -154,508 2,683,282
2021-06-08 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8,000 146,933 5.76 16.43 131,440 2,414,109
2021-06-08 2021-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 17,182 17,182
2021-06-08 2021-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
D - Sale to Issuer -7,827 8,000 -49.45
2021-06-08 2021-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 6,019 138,933 4.53
2021-06-08 2021-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -7,827 132,914 -5.56 19.28 -150,941 2,563,207
2021-06-08 2021-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7,827 140,741 5.89 16.43 128,598 2,312,375
2021-05-24 2021-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 15,827 -38.72
2021-05-24 2021-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,000 132,914 -7.00 19.74 -197,354 2,623,111
2021-05-24 2021-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 142,914 7.52 16.43 164,300 2,348,077
2020-06-15 2020-06-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -355 132,914 -0.27 19.58 -6,951 2,602,456
2020-06-09 2020-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 16,004 16,004
2020-06-09 2020-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 5,851 133,269 4.59
2020-06-09 2020-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -663 127,418 -0.52 19.52 -12,942 2,487,199
2020-05-27 2020-05-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2020-05-27 2020-05-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,000 128,081 -7.24 18.60 -185,989 2,382,166
2020-05-27 2020-05-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 138,081 7.81 15.11 151,100 2,086,404
2020-05-27 2020-05-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 10,000 -50.00
2020-05-27 2020-05-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,000 128,081 -7.24 18.36 -183,639 2,352,067
2020-05-27 2020-05-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 138,081 7.81 15.11 151,100 2,086,404
2020-05-22 2020-05-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 20,000 -33.33
2020-05-22 2020-05-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,000 128,081 -7.24 18.47 -184,687 2,365,490
2020-05-22 2020-05-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 138,081 7.81 15.11 151,100 2,086,404
2020-05-22 2020-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -17,782 30,000 -37.21
2020-05-22 2020-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -17,782 128,081 -12.19 18.43 -327,779 2,360,943
2020-05-22 2020-05-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 17,782 145,863 13.88 15.11 268,686 2,203,990
2019-06-13 2019-06-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 13,915 13,915
2019-06-13 2019-06-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 5,491 128,081 4.48
2019-06-10 2019-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -791 122,590 -0.64 20.11 -15,907 2,465,285
2018-12-07 2018-12-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -9,278 0 -100.00
2018-12-07 2018-12-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -9,278 123,381 -6.99 21.89 -203,064 2,700,391
2018-12-07 2018-12-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 9,278 132,659 7.52 14.66 136,015 1,944,781
2018-12-07 2018-12-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 9,278 -51.87
2018-12-07 2018-12-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -5,794 123,381 -4.49 21.45 -124,294 2,646,794
2018-12-07 2018-12-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -4,206 129,175 -3.15 20.91 -87,947 2,701,049
2018-12-07 2018-12-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 133,381 8.10 14.66 146,600 1,955,365
2018-12-07 2018-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,000 19,278 -34.16
2018-12-07 2018-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1,011 123,381 -0.81 22.55 -22,794 2,781,686
2018-12-07 2018-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -8,989 124,392 -6.74 21.84 -196,365 2,717,343
2018-12-07 2018-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,000 133,381 8.10 14.66 146,600 1,955,365
2018-06-11 2018-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,754 123,381 -1.40 16.67 -29,239 2,056,761
2018-06-11 2018-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 16,679 16,679
2018-06-11 2018-06-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 6,590 125,135 5.56
2017-06-12 2017-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,826 118,545 -1.52 16.84 -30,750 1,996,298
2017-06-12 2017-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 20,291 20,291
2017-06-12 2017-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 5,844 120,371 5.10
2016-11-16 2016-11-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -17,994 0 -100.00
2016-11-16 2016-11-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -17,994 114,527 -13.58 20.76 -373,510 2,377,294
2016-11-16 2016-11-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 17,994 132,521 15.71 14.23 256,055 1,885,774
2016-11-16 2016-11-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -20,000 17,994 -52.64
2016-11-16 2016-11-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -20,000 114,527 -14.87 20.56 -411,170 2,354,503
2016-11-16 2016-11-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 20,000 134,527 17.46 14.23 284,600 1,914,319
2016-09-02 2016-09-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -10,381 0 -100.00
2016-09-02 2016-09-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10,381 114,527 -8.31 18.78 -194,917 2,150,393
2016-09-02 2016-09-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,381 125 -101.22 15.23 158,103 1,902
2016-06-13 2016-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 25,827 25,827
2016-06-13 2016-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 6,086 114,527 5.61
2016-06-01 2016-05-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,460 108,441 -1.33 15.75 -22,995 1,707,946
2015-12-17 2015-12-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -1,926 0 -100.00
2015-12-17 2015-12-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1,926 109,901 -1.72 14.33 -27,600 1,574,881
2015-12-17 2015-12-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 1,926 111,827 1.75 11.68 22,496 1,306,139
2015-12-17 2015-12-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -36,536 1,926 -94.99
2015-12-17 2015-12-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -36,536 109,901 -24.95 14.34 -523,999 1,576,200
2015-12-17 2015-12-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 36,536 146,437 33.24 11.68 426,740 1,710,384
2015-05-29 2015-05-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 47,782 47,782
2015-05-29 2015-05-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 8,686 109,901 8.58
2014-08-27 2014-08-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
P - Purchase 6,000 101,215 6.30 10.84 65,022 1,096,867
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
184,973
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
100,672
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
184,973
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
100,672
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)